Through cancer trials, doctors hope to find new ways to improve patients’ cancer treatments and quality of life. Clinical trials provide access to innovative and experimental therapies to patients with solid and circulating tumors, including through the National Cancer Institute’s Clinical Trials Network (NCTN). Our centralized clinical research team is comprised of research nurses, data managers, and regulatory coordinators.

Investigative research, provides the ability to identify, develop and study new innovations in a real health system setting. While cancer care has already made tremendous progress, further innovation and research is necessary to develop and implement the next generation of therapeutics, best practices and disease prevention and targeted treatments targeted to the precise needs of the patient.

As part of the AdventHealth Oncology Research program In the Rocky Mountain Region we can access clinical trials that lead to investigational treatments and experiential cancer therapies.

Our research is conducted by our dedicated team of physicians determined to find the effectiveness of a new drugs or technology in a real-world setting. Investigational treatments provide patients with additional treatment options otherwise not available while contributing to cancer research.

For more information on current clinical trials, patient eligibility and other considerations, call us at 303-765-6775.